{"id":499976,"date":"2021-06-02T08:24:28","date_gmt":"2021-06-02T12:24:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/"},"modified":"2021-06-02T08:24:28","modified_gmt":"2021-06-02T12:24:28","slug":"nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/","title":{"rendered":"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

STANS, Switzerland<\/span>, June 2, 2021<\/span> \/PRNewswire\/ — NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ:\u00a0NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that Alex Zwyer<\/span>, Chief Executive Officer and Co-Founder, is scheduled to present a corporate overview at the LD Micro Virtual Invitational Conference\u00a0being held on
June 8<\/span> \u2013 June 10<\/span>, 2021.\u00a0 <\/p>\n

\n

\n
\n \"(PRNewsfoto\/NLS
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Mr. Zwyer will deliver his corporate presentation on June 10<\/span> at 11:30am ET<\/span>, Track 2 and the presentation can be viewed here<\/a>. Investors attending the conference and interested in scheduling a meeting with management should contact\u00a0assistant@ldmicro.com<\/a>.<\/p>\n

\n About NLS Pharmaceutics Ltd.<\/b>\n <\/p>\n

NLS Pharmaceutics Ltd. is a Swiss-based clinical-stage biopharmaceutical company led by an experienced management team with a track record of developing and repurposing product candidates to treat rare and complex central nervous system disorders. The Company’s lead product candidate, Quilience\u00ae<\/span> is a proprietary controlled-release formulation of mazindol (mazindol CR), and is being developed for the treatment of narcolepsy. Mazindol is a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, which was used for many years to treat patients diagnosed with narcolepsy in compassionate use programs. NLS completed a phase 2 study in the U.S. evaluating mazindol CR in adult subjects with ADHD. The study met all primary and secondary endpoints and was well-tolerated. Quilience has received Orphan Drug Designations both in the U.S. and in\u00a0Europe\u00a0for the treatment of narcolepsy.<\/p>\n

\n Corporate Contact
<\/b>
\n Alex Zwyer<\/span>, CEO: +41 41 618 80 00\u00a0 <\/p>\n

\n Investor Relations Contact
<\/b>
\n Cindy Rizzo<\/span>: +1 908-229-7050\u00a0 <\/p>\n

\n www.nlspharma.com<\/a>\n <\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021-301302766.html<\/a><\/p>\n

SOURCE NEUROLIFESCIENCES<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire STANS, Switzerland, June 2, 2021 \/PRNewswire\/ — NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ:\u00a0NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that Alex Zwyer, Chief Executive Officer and Co-Founder, is scheduled to present a corporate overview at the LD Micro Virtual Invitational Conference\u00a0being held on June 8 \u2013 June 10, 2021.\u00a0 Mr. Zwyer will deliver his corporate presentation on June 10 at 11:30am ET, Track 2 and the presentation can be viewed here. Investors attending the conference and interested in scheduling a meeting with management should contact\u00a0assistant@ldmicro.com. About NLS Pharmaceutics Ltd. NLS Pharmaceutics Ltd. is a Swiss-based … <\/p>\n

Continue reading “NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-499976","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire STANS, Switzerland, June 2, 2021 \/PRNewswire\/ — NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ:\u00a0NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that Alex Zwyer, Chief Executive Officer and Co-Founder, is scheduled to present a corporate overview at the LD Micro Virtual Invitational Conference\u00a0being held on June 8 \u2013 June 10, 2021.\u00a0 Mr. Zwyer will deliver his corporate presentation on June 10 at 11:30am ET, Track 2 and the presentation can be viewed here. Investors attending the conference and interested in scheduling a meeting with management should contact\u00a0assistant@ldmicro.com. About NLS Pharmaceutics Ltd. NLS Pharmaceutics Ltd. is a Swiss-based … Continue reading "NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-02T12:24:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1424227\/NLS_Pharm_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021\",\"datePublished\":\"2021-06-02T12:24:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/\"},\"wordCount\":289,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1424227\\\/NLS_Pharm_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/\",\"name\":\"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1424227\\\/NLS_Pharm_Logo.jpg\",\"datePublished\":\"2021-06-02T12:24:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1424227\\\/NLS_Pharm_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1424227\\\/NLS_Pharm_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/","og_locale":"en_US","og_type":"article","og_title":"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021 - Market Newsdesk","og_description":"PR Newswire STANS, Switzerland, June 2, 2021 \/PRNewswire\/ — NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ:\u00a0NLSPW) (“NLS” or the “Company”), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that Alex Zwyer, Chief Executive Officer and Co-Founder, is scheduled to present a corporate overview at the LD Micro Virtual Invitational Conference\u00a0being held on June 8 \u2013 June 10, 2021.\u00a0 Mr. Zwyer will deliver his corporate presentation on June 10 at 11:30am ET, Track 2 and the presentation can be viewed here. Investors attending the conference and interested in scheduling a meeting with management should contact\u00a0assistant@ldmicro.com. About NLS Pharmaceutics Ltd. NLS Pharmaceutics Ltd. is a Swiss-based … Continue reading \"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-02T12:24:28+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1424227\/NLS_Pharm_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021","datePublished":"2021-06-02T12:24:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/"},"wordCount":289,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1424227\/NLS_Pharm_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/","name":"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1424227\/NLS_Pharm_Logo.jpg","datePublished":"2021-06-02T12:24:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1424227\/NLS_Pharm_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1424227\/NLS_Pharm_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nls-pharmaceutics-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=499976"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499976\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=499976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=499976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=499976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}